NCT06172803Completed
Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
RESToRE: Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
Source: ClinicalTrials.gov · Last updated 6 Jun 2024
Brief summary (registry, in English)
The overall goal of this study is to find out if rehabilitation exercise can help people who have long COVID. Participants will be randomized by chance to receive either aerobic exercise or breathing exercise (combined with stretches). Participants will be guided and supported in completing a tailored, 6-week home exercise program to be performed 5 - 6 days a week, prescribed and supervised by rehabilitation therapists. Participants will perform breathing exercises, which will be supervised by an occupational therapist. The focus of Aim 1 is to determine feasibility of implementing RESToRE in long COVID.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 4 (actual)
- First submitted
- 14 Dec 2023
- Start date
- 1 Oct 2023
- Primary completion date
- 15 Jan 2024
- Lead sponsor
- Columbia University
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06172803
What you commit to
- Study type: Interventional
- Participants enrolled: 4
- From 1 Oct 2023 to the primary completion date, 15 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of chronic cardiac or pulmonary disease, including atrial fibrillation, ME/CFS, post-concussion syndrome, chronic Lyme disease, lupus, or sarcopenia comorbidities (due to PEM and/or fatigue)
- Medical history of ICU stay for COVID-19 illness due to risk of post-ICU syndrome and increased rehabilitation needs
- Diagnosis of dementia or neurodegenerative disease, multiple sclerosis, or rheumatoid arthritis with associated cognitive dysfunction or fatigue.
Age
- \>70years old due to risk of sarcopenia
Other
- Frailty defined as gait speed \<1 m/s on 4- Meter Gait Speed (4MGS) test due to falls risk
- Inability to ambulate independently and safely without a walking aide
Who the study is looking for
- English speaking
- Age of 21 years or older
- Diagnosis of long COVID
- Score \>0 on energy, daily activities, sleep, chest tightness, or breathlessness on COPD Assessment Test or self-reported brain fog
- Able to use a smartphone.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.